当前位置: 首页 >> 检索结果
7241. Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy.
作者: Yoshiyuki Abe.;Makio Kusaoi.;Kurisu Tada.;Ken Yamaji.;Naoto Tamura.
来源: Rheumatology (Oxford). 2020年59卷4期767-771页
We examined the effectiveness of plasma exchange (PE) therapy to reduce the mortality of rapidly progressive interstitial lung disease (RP-ILD) in patients positive for anti-melanoma differentiation-associated gene 5 (MDA5) antibodies.
7244. Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.
作者: Mathieu Puyade.;Nancy Maltez.;Pauline Lansiaux.;Grégory Pugnet.;Pascal Roblot.;Ines Colmegna.;Marie Hudson.;Dominique Farge.
来源: Rheumatology (Oxford). 2020年59卷4期779-789页
In severe rapidly progressive SSc, autologous haematopoietic stem cell transplantation (AHSCT) allows significant improvements in overall and event-free survival. We undertook this study to identify, appraise and synthesize the evidence on health-related quality of life (HRQoL) before and after AHSCT for SSc.
7245. Trends in all-cause and cardiovascular mortality in patients with incident rheumatoid arthritis: a 20-year follow-up matched case-cohort study.
作者: Sella A Provan.;Siri Lillegraven.;Joe Sexton.;Kristin Angel.;Cathrine Austad.;Espen A Haavardsholm.;Tore K Kvien.;Till Uhlig.
来源: Rheumatology (Oxford). 2020年59卷3期505-512页
To examine all-cause and cardiovascular disease (CVD) mortality in consecutive cohorts of patients with incident RA, compared with population comparators.
7246. STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE.
作者: Aurélie De Groof.;Julie Ducreux.;Floor Aleva.;Andrew J Long.;Alina Ferster.;Andre van der Ven.;Frank van de Veerdonk.;Frédéric A Houssiau.;Bernard R Lauwerys.
来源: Rheumatology (Oxford). 2020年59卷3期668-677页
Type I IFNs play a well-known role in the pathogenesis of SLE, through activation of CD4 T and antigen-presenting cells. Here, we investigated the effects of IFN alpha (IFNα) on SLE B cell activation and differentiation.
7247. Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.
作者: Kathleen M M Vanni.;Houchen Lyu.;Daniel H Solomon.
来源: Rheumatology (Oxford). 2020年59卷4期709-717页
To conduct a systematic literature review and meta-analysis to estimate the incidence of anaemia, leucopoenia, neutropenia and thrombocytopenia associated with MTX plus folic acid among patients with rheumatic diseases.
7248. Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c.
作者: Sandra Parra.;Mercedes Heras.;Pol Herrero.;Nuria Amigó.;Esperanza Garcés.;Josefa Girona.;Xavier Correig.;Nuria Canela.;Antoni Castro.
来源: Rheumatology (Oxford). 2020年59卷3期650-661页
To identify potential biomarkers of disease activity analysing the proteome of high-density lipoprotein (HDL) particles from SLE patients in clinical remission and when they develop a flare compared with a healthy control group.
7249. Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis.
作者: Marie-Astrid Boutet.;Alessandra Nerviani.;Gloria Lliso-Ribera.;Davide Lucchesi.;Edoardo Prediletto.;Giulia Maria Ghirardi.;Katriona Goldmann.;Myles Lewis.;Costantino Pitzalis.
来源: Rheumatology (Oxford). 2020年59卷4期828-838页
IL-36 agonists are pro-inflammatory cytokines involved in the pathogenesis of psoriasis. However, their role in the pathogenesis of arthritis and treatment response to DMARDs in PsA remains uncertain. Therefore, we investigated the IL-36 axis in the synovium of early, treatment-naïve PsA, and for comparison RA patients, pre- and post-DMARDs therapy.
7250. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.
作者: Daniel Li.;Kazuki Yoshida.;Candace H Feldman.;Cameron Speyer.;Medha Barbhaiya.;Hongshu Guan.;Daniel H Solomon.;Brendan M Everett.;Karen H Costenbader.
来源: Rheumatology (Oxford). 2020年59卷3期697页 7251. Monosodium urate crystal interleukin-1β release is dependent on Toll-like receptor 4 and transient receptor potential V1 activation.
作者: Mateus F Rossato.;Carin Hoffmeister.;Gabriela Trevisan.;Fabio Bezerra.;Thiago M Cunha.;Juliano Ferreira.;Cassia R Silva.
来源: Rheumatology (Oxford). 2020年59卷1期266页 7252. Can artificial intelligence replace manual search for systematic literature? Review on cutaneous manifestations in primary Sjögren's syndrome.
作者: Laure Orgeolet.;Nathan Foulquier.;Laurent Misery.;Pascal Redou.;Jacques-Olivier Pers.;Valérie Devauchelle-Pensec.;Alain Saraux.
来源: Rheumatology (Oxford). 2020年59卷4期811-819页
Manual systematic literature reviews are becoming increasingly challenging due to the sharp rise in publications. The primary objective of this literature review was to compare manual and computer software using artificial intelligence retrieval of publications on the cutaneous manifestations of primary SS, but we also evaluated the prevalence of cutaneous manifestations in primary SS.
7253. Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma.
作者: Alicia M Hinze.;Cheng T Lin.;Amira F Hussien.;Jamie Perin.;Aida Venado.;Jeffrey A Golden.;Francesco Boin.;Robert H Brown.;Robert A Wise.;Fredrick M Wigley.
来源: Rheumatology (Oxford). 2020年59卷4期790-798页
To investigate the natural history of fibrotic lung disease in recipients of a single lung transplant for scleroderma-associated interstitial lung disease (ILD).
7254. The association between lymphopenia and serious infection risk in rheumatoid arthritis.
作者: Sujith Subesinghe.;Alexander Kleymann.;Andrew Ian Rutherford.;Katie Bechman.;Sam Norton.;James Benjamin Galloway.
来源: Rheumatology (Oxford). 2020年59卷4期762-766页
To investigate the relationship between occurrence of serious infection (SI) and lymphocyte counts in patients with RA using data from a single centre.
7256. Haematological abnormalities in new-onset rheumatoid arthritis and risk of common infections: a population-based study.
作者: Elena Nikiphorou.;Simon de Lusignan.;Christian Mallen.;Kaivan Khavandi.;Jacqueline Roberts.;Christopher D Buckley.;James Galloway.;Karim Raza.
来源: Rheumatology (Oxford). 2020年59卷5期997-1005页
To describe the prevalence of haematological abnormalities in individuals with RA at the point of diagnosis in primary care and the associations between haematological abnormalities, vaccinations and subsequent risk of common infections.
7257. The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretion.
作者: Lewis C Rodgers.;John Cole.;Kevin M Rattigan.;Michael P Barrett.;Nisha Kurian.;Iain B McInnes.;Carl S Goodyear.
来源: Rheumatology (Oxford). 2020年59卷4期869-878页
Fatty acid oxidation (FAO) and glycolysis have been implicated in immune regulation and activation of macrophages. However, investigation of human monocyte intracellular metabolism in the context of the hypoxic and inflammatory rheumatoid arthritis (RA) synovium is lacking. We hypothesized that exposure of monocytes to the hypoxic and inflammatory RA environment would have a profound impact on their metabolic state, and potential to contribute to disease pathology.
7259. Unique Sjögren's syndrome patient subsets defined by molecular features.
作者: Judith A James.;Joel M Guthridge.;Hua Chen.;Rufei Lu.;Rebecka L Bourn.;Krista Bean.;Melissa E Munroe.;Miles Smith.;Eliza Chakravarty.;Alan N Baer.;Ghaith Noaiseh.;Ann Parke.;Karen Boyle.;Lynette Keyes-Elstein.;Andreea Coca.;Tammy Utset.;Mark C Genovese.;Virginia Pascual.;Paul J Utz.;V Michael Holers.;Kevin D Deane.;Kathy L Sivils.;Teresa Aberle.;Daniel J Wallace.;James McNamara.;Nathalie Franchimont.;E William St Clair.
来源: Rheumatology (Oxford). 2020年59卷4期860-868页
To address heterogeneity complicating primary SS (pSS) clinical trials, research and care by characterizing and clustering patients by their molecular phenotypes.
7260. EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus.
作者: Clarice Gabardo Ritter.;Camila de David Cruz.;Sheron Zamboni.;Vanessa Barrili Busato.;Romulo Gomes da Silveira.;Valentina Oliveira Provenzi.;Markus Bredemeier.
来源: Rheumatology (Oxford). 2020年59卷4期916页 |